Science · Open for opinions
Will any epigenetic editing therapy against Hepatitis B have a clinical trial approved by the FDA by October 31, 2026?
Consider FDA clinical trial regulatory decisions between 09/22 and 10/31/2026 [0]. 57 opinions, 70% No
- Yes — 30%
- No — 70%
Deadline: October 31, 2026 at 11:59 PM UTC · 57 opinions
Resolution rules
Consider FDA clinical trial regulatory decisions between 09/22 and 10/31/2026 [0].
Source: www.nature.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 22/09/2026 (00:00, horário de Brasília) até 31/10/2026 (23:59). Fatos, anúncios ou eventos anteriores ao início da janela não contam. Resolve como 'Sim' se a FDA aprovar autorização de ensaio clínico (IND) para terapia de edição epigenética contra o vírus da Hepatite B até 31/10/2026, conforme registros oficiais no fda.gov ou clinicaltrials.gov. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 70% of the votes: an opinion on it that turns out right earns about 30 points, a wrong one costs about 70.